Skip to main content
Schott Pharma logo

Schott Pharma — Investor Relations & Filings

Ticker · 1SXP ISIN · DE000A3ENQ51 LEI · 529900TU48UE99NHEY88 F Manufacturing
Open in API
Filings indexed 134 across all filing types
Latest filing 2024-09-27 Declaration of Voting R…
Country DE Germany
Listing F 1SXP

About Schott Pharma

https://www.schott-pharma.com/en

Schott Pharma is a developer and manufacturer of drug containment solutions and delivery systems for injectable drugs. Serving the pharmaceutical and biotech industries, its portfolio includes prefillable syringes, cartridges, vials, and ampoules. The company provides scientifically proven products designed for the safe storage and administration of medications. Beyond individual components, Schott Pharma offers complete, compatible systems and a range of services, including analytical, development, fill-and-finish, and regulatory support. This integrated approach supports clients from clinical trials through to commercialization, ensuring compatibility across the entire pharma value chain.

Recent filings

Filing Released Lang Actions
Declaration of Voting Results & Voting Rights Announcements 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables reporting changes in share ownership ('Notification of Major Holdings') by a specific entity (T. Rowe Price Group, Inc.) crossing ownership thresholds as mandated by German securities law (WpHG). This directly corresponds to the definition of a Major Shareholding Notification, which tracks changes in significant ownership levels crossing thresholds. Although the document mentions 'Voting Rights Announcements' in the header, the content structure (reporting direct/indirect holdings, instruments, and threshold crossing dates) aligns perfectly with the 'Major Shareholding Notification' category (MRQ). It is not an AGM material, an earnings release, or a full annual report.
2024-09-27 English
SCHOTT Pharma, Gerresheimer, and Stevanato Group announce strategic industry Alliance for RTU
Regulatory Filings Classification · 1% confidence The document is a news release dated September 26, 2024, announcing a strategic industry alliance ("Alliance for RTU") between three companies (SCHOTT Pharma, Gerresheimer, and Stevanato Group) regarding ready-to-use pharmaceutical containers. It details the purpose, benefits, and future presentation of this alliance. This type of announcement, which is a general corporate update about a strategic partnership and does not fit the specific definitions for financial reports (10-K, IR, ER), management changes (MANG), or capital actions (CAP, SHA), is best classified as a general regulatory announcement or news release. Since it is not a formal regulatory filing like a 10-K or a specific report like an AR or ER, and it is not merely announcing the publication of another report (RPA), the most appropriate fallback category is Regulatory Filings (RNS) for miscellaneous corporate news distributed via a news service (EQS-News).
2024-09-26 English
Articles of association of the company (German)
Governance Information Classification · 1% confidence The document is the 'Satzung' (Articles of Association) of SCHOTT Pharma AG & Co. KGaA. This document outlines the company's legal structure, purpose, capital, and governance rules. In the context of corporate filings, the Articles of Association are fundamental governance documents that define the internal rules and board structure of the company. Therefore, it falls under the Governance Information category.
2024-09-17 German
Articles of association of the company (German)
Regulatory Filings Classification · 1% confidence The document text consists of sections titled "SATZUNG" (Statutes/Bylaws) for "SCHOTT Pharma AG & Co. KGaA". It details the company's name, seat, business purpose, capital structure (Grundkapital, Genehmigtes Kapital, Bedingtes Kapital), share structure, and governance framework (Persönlich haftende Gesellschafterin, Aufsichtsrat). This content is characteristic of a company's foundational legal document, which is typically filed as part of corporate governance or incorporation documents. Among the provided codes, 'Governance Information' (CGR) is the most appropriate fit for detailed statutes outlining structure and rules, although it is not a standard SEC filing type like 10-K or DEF 14A. Given the nature of the text (company statutes), CGR (Governance Information) is the best classification.
2024-09-17 German
Satzung der Gesellschaft
Regulatory Filings Classification · 1% confidence The document text consists of sections titled "SATZUNG" (Statutes/Bylaws) for "SCHOTT Pharma AG & Co. KGaA". It details the company's name, seat, business purpose, capital structure (Grundkapital, Genehmigtes Kapital, Bedingtes Kapital), share structure, and governance framework (Persönlich haftende Gesellschafterin, Aufsichtsrat). This content is characteristic of a company's foundational legal document, which is typically filed as part of corporate governance or incorporation documents. Among the provided codes, 'Governance Information' (CGR) is the most appropriate fit for detailed statutes outlining structure and rules, although it is not a standard SEC filing type like 10-K or DEF 14A. Given the nature of the text (company statutes), CGR (Governance Information) is the best classification.
2024-09-17 German
Promotion for SCHOTT Pharma: Listed on the MDAX for the first time
Delisting Announcement Classification · 1% confidence The document is a news release announcing that SCHOTT Pharma AG & Co. KGaA will be promoted to the MDAX index starting September 23, 2024. It discusses stock market listing changes, which are significant corporate events related to capital structure and market visibility. This type of announcement, which is not a standard periodic financial report (like 10-K or IR), nor a specific insider trade (DIRS) or dividend notice (DIV), fits best under the general category for corporate news or regulatory updates that don't have a more specific code. Since it is a general corporate announcement disseminated via EQS News, and it doesn't fit perfectly into the other specific categories (like M&A, Capital Change, or Earnings Release), the most appropriate fallback is Regulatory Filings (RNS), which covers general regulatory announcements.
2024-09-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.